Dulera® (mometasone furoate/formoterol fumarate dihydrate) – Expanded indication, new strength
August 12, 2019 - FDA approved Merck’s Dulera (mometasone furoate/ formoterol fumarate dihydrate) inhalation aerosol, for the twice-daily treatment of asthma in patients 5 years of age and older.
Download PDF
